ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      82.015
      0.04%
      Bitcoin
      68,773.43
      0.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Virax Biolabs Group Ltd (VRAX)

      7. Virax Biolabs Group Ltd (VRAX) News

      VRAX

      Virax Biolabs (VRAX)

      Virax Biolabs Group Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VRAX
      DateTimeSourceHeadlineSymbolCompany
      04/25/20248:00AMPR Newswire (US)Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
      04/16/20247:30AMPR Newswire (US)Virax Biolabs to Participate at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
      03/15/20244:30PMPR Newswire (US)Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:VRAXVirax Biolabs Group Ltd
      01/22/20245:28PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      01/22/20245:27PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
      01/12/20247:43AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/21/20237:34AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/21/20237:30AMPR Newswire (US)Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsNASDAQ:VRAXVirax Biolabs Group Ltd
      12/20/20234:12PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/20/20234:12PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/20/20234:06PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/20/20234:03PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/18/20237:37AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/18/20237:30AMPR Newswire (US)Virax Biolabs' CEO James Foster Issues Letter to ShareholdersNASDAQ:VRAXVirax Biolabs Group Ltd
      12/18/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VRAXVirax Biolabs Group Ltd
      12/14/20237:43AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/14/20237:30AMPR Newswire (US)Virax Biolabs Group Limited Announces 1-for-10 Share ConsolidationNASDAQ:VRAXVirax Biolabs Group Ltd
      12/08/20236:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      12/05/20234:06PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:VRAXVirax Biolabs Group Ltd
      11/08/20234:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      10/31/20234:38PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      10/17/20234:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VRAXVirax Biolabs Group Ltd
      10/12/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      10/04/20237:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      09/12/20237:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      09/12/20237:30AMPR Newswire (US)Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarNASDAQ:VRAXVirax Biolabs Group Ltd
      09/01/20237:37AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      09/01/20237:30AMPR Newswire (US)Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumNASDAQ:VRAXVirax Biolabs Group Ltd
      08/03/20238:39AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
      08/03/20237:30AMPR Newswire (US)Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidNASDAQ:VRAXVirax Biolabs Group Ltd
       Showing the most relevant articles for your search:NASDAQ:VRAX

      Your Recent History

      BIT
      F18300
      Vontobel Financial Produ...
      BIT
      UB7HN8
      Unicredit Bank
      Delayed Upgrade Clock